4//SEC Filing
Portnoy Mark L. 4
Accession 0001209191-23-001972
CIK 0000862692other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:26 PM ET
Size
14.3 KB
Accession
0001209191-23-001972
Insider Transaction Report
Form 4
Portnoy Mark L.
DirectorCo-CEO10% Owner
Transactions
- Award
Stock Option
2023-01-03$4.77/sh+25,000$119,250→ 25,000 totalExercise: $4.77From: 2023-01-03Exp: 2028-01-03→ Common Stock (25,000 underlying)
Holdings
- 20,000
Stock Option
Exercise: $7.28From: 2019-12-20Exp: 2029-12-20→ Common Stock (20,000 underlying) - 100,000
Stock Option
Exercise: $12.27From: 2021-12-22Exp: 2028-12-22→ Common Stock (100,000 underlying) - 20,000
Stock Option
Exercise: $7.92From: 2018-03-08Exp: 2023-03-08→ Common Stock (20,000 underlying) - 20,000
Stock Option
Exercise: $13.50From: 2021-12-22Exp: 2024-12-22→ Common Stock (20,000 underlying) - 42,266(indirect: By 401(k))
Common Stock
- 71,529(indirect: By Partnership)
Common Stock
- 821,973
Common Stock
- 22,222
Stock Option
Exercise: $7.53From: 2019-08-30Exp: 2029-08-30→ Common Stock (22,222 underlying)
Footnotes (5)
- [F1]Shares of Common Stock held by Capital Asset Fund #1 Limited Partnership, as to which Mark L. Portnoy may be deemed the beneficial owner as its general partner.
- [F2]The stock options are subject to the approval of the 2022 Equity Incentive Plan, which vote is expected to occur at the Company's 2022 Annual Meeting.
- [F3]One-third of the stock options will vest on December 22, 2022, one-third will vest on December 22, 2023 and one-third on December 22, 2024.
- [F4]Stock options vest immediately if the price of the Company's stock reaches $25.00 per share during the seven-year option term.
- [F5]11,250 options vest upon issuance, 11,250 options vest on 1/2/2024 and 2,500 options vest on 1/2/2025.
Documents
Issuer
CRYO CELL INTERNATIONAL INC
CIK 0000862692
Entity typeother
Related Parties
1- filerCIK 0001529249
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:26 PM ET
- Size
- 14.3 KB